Weekly Roundup – June 29

Bed Bath & Beyond (BBBY): Analysts Expect BBBY Estimates to Fall Short of Management Guidance

Last week, Bed Bath & Beyond reported 1Q17 results that were well-below expectations. The results were highlighted by -2.0% comparable store sales growth, which compared to the company’s full-year guidance of “relatively flat to slightly positive” comparable store sales growth. Reported EPS of $0.53 was also well-below consensus of $0.66. Read more…

Medtronic (MDT): Diabetes Group Expected to Become a Larger Driver of Revenue Growth

With $1.9B in revenue last year, the Diabetes Group at Medtronic represented just 6% of sales. However, management is aiming to grow the segment significantly over the next several years. Read more…

Darden (DRI): Consensus Expecting Comparable Restaurant Sales Acceleration in 4Q17

Darden will report fiscal 4Q17 results on Tuesday before market open. This will be one of the first restaurants to report on results in calendar 2Q, and therefore will be watched closely by the industry. Read more…

Renewed Interest in Retailers Brings Attention to Dick’s Sporting Goods

After numerous years of bankruptcies and heightening concerns from the ascent of e-commerce, investors are beginning to see value again in brick and mortar retailers. Read more…

Tesla (TSLA): Analysts See 14,000 in Model 3 Sales in 2017

Tesla is juggling a number of different resource-heavy goals. Most importantly, the company plans to launch its next car, the Model 3, in 2017. As a result of all of the balls in the air, and Tesla’s small margin for error given its vertical integration, many analysts do not expect the company to hit all of its targets by their stated timeline. Read more…